Skip to content

Clinical trials

Terminated Phase 3 Anemia, Sickle Cell trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anemia, Sickle Cell Phase: Phase 3 Status: Terminated Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20066
20071
20091
20101
20111
20121
20131
20152
20182
20193
20201
20211
20224

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated27

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer7
Actelion3
Children's Hospital Medical Center, Cincinnati3
Icagen2
Abigail Nixon1
AstraZeneca1
Baylor College of Medicine1
Carelon Research1
Children's Hospital Los Angeles1
Duke University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anemia, Sickle Cell27
Vaso-Occlusive Crises7
Hematologic Diseases3
Hypertension, Pulmonary3
Acute Chest Syndrome1
Agnosia1
Hemochromatosis1
Iron Overload1
Leg Ulcer1
Primary Dysautonomias1

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.